ABSTRACT Fungal endocarditis is an uncommon but important problem after cardiac surgery. Two cases of fungal endocarditis after homograft valve replacement are reported. In both patients prolonged periods of antifungal chemotherapy with apparently satisfactory clinical responses ultimately failed to eradicate the infection. Both patients remain free of infection two years after excision of the infected valves and further chemotherapy. The value of serial estimations of fungal antibody titres in diagnosis and treatment is demonstrated and the necessity for early operation is emphasised.
Fungal endocarditis is an uncommon complication of open-heart surgery but it is important because of its grave prognosis. Since classical features of endocarditis may not be present and blood cultures may be persistently negative, the diagnosis is often not made until late in the course of the disease, sometimes after serious embolism has occurred. The following reports of two cases of fungal endocarditis after homograft aortic valve replacement illustrate these difficulties, and the use of fungal antibody titres and echocardiography as aids to diagnosis is discussed. In both patients antifungal chemotherapy alone failed to eradicate the infection and the need for treatment with a combination of early operation and antifungal agents is emphasised. Invasiveness is enhanced when the bacterial flora is disturbed by broad spectrum antibiotics, and these are given prophylactically at the time of the operation and for five days afterwards. It is thought unlikely that the homograft valves were infected by fungi before insertion, as the method of preiparation involves storage in a solution containing a high concentration of nystatin as well as antibacterial agents. In addition, pieces of valve tissue are cultured for bacteria and fungi before the valve is accepted for surgical use. ' It is unwise to ignore the isolation of fungi from the blood as fungal endocarditis has been recorded up to 18 months after apparently transient fungaemia.3 Classical signs of endocarditis often do not occur until late in the course of the disease, and in a significant proportion of cases may be absent. Arterial emboli may be the first manifestation and they occur more commonly and tend to be larger than in bacterial endocarditis.4 5 The prognosis of fungal endocarditis is poor and a means of earlier diagnosis is needed. Antibody titres were raised in both the patients described. Although antifungal chemotherapy produced clinical remissions, in case 1 the antibody titres did not fall and in case 2 they fell but not to low levels. In both patients systemic embolism was associated with a rise in titres and at operation both patients had viable fungi in their homografts. After operation the titres fell to and remained at low levels.
Precipitin titres were assayed by counter-immunoelectrophoresis using a preparation containing cytoplasmic antigens. Agglutinin titres were obtained using whole cells. Precipitin and agglutinin titres moved in the same direction but the precipitin titre was more stable, and changes were consistently associated with changes in the clinical condition.
In reported medical cures of Candida endocarditis the diagnosis has usually been based on the finding of fungaemia alone, without definite evidence of fungal invasion of heart valves.10 Several reported cures have been followed by relapse up to one year after treatment was discontinued." Failure of chemotherapy may be the result of poor penetration of amphotericin B into the vegetations of fungal endocarditis. Cultures positive for Candida have been obtained after incubation of homogenised vegetation in a medium containing 12-8 gg/ml of amphotericin B for 168 hours. '2 The best chance of cure and of preventing potentially dangerous arterial embolism is provided by excision of the infected valve and removal of any other lesions. The infected area should be irrigated with amphotericin B at the time of operation, and this should be followed by systemic antifungal therapy.'3 Antibody titres should be estimated regularly until at least a year after cessation of chemotherapy: if treatment has been successful titres should fall to a low level. A significant rise in titres or persistence of high titres should be regarded as indicating
